These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 778311)

  • 1. Defective leukotaxis in patients with lepromatous leprosy.
    Ward PA; Goralnick S; Bullock WE
    J Lab Clin Med; 1976 Jun; 87(6):1025-32. PubMed ID: 778311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective leukotaxis in patients with lepromatous leprosy.
    Ward PA; Goralnick S; Bullock WE
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):243-9. PubMed ID: 945238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phagocytosis in leprosy. III. Defective adhesive and endocytic abilities of circulating leukocytes in lepromatous leprosy.
    Rojas-Espinosa O; Aponte-Vázquez J; González Cruz O; Estrada-Parra S; Ortiz Y
    Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):159-66. PubMed ID: 7190552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum factors affecting the cell migration inhibition response to lepromin.
    Fliess EL; Ruibal-Ares B; Braun M
    Int J Lepr Other Mycobact Dis; 1975; 43(4):320-6. PubMed ID: 1241688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed hypersensitivity tests with Mycobacterium leprae purified protein derivative.
    Bedi BM; Harris EB; Narayanan E; Kirchheimer WF
    Lepr India; 1976 Jan; 48(1):8-18. PubMed ID: 1035779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy.
    Sengupta U; Sinha S; Ramu G; Lamb J; Ivanyi J
    Clin Exp Immunol; 1987 Apr; 68(1):58-64. PubMed ID: 3308210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type.
    Laal S; Mishra RS; Nath I
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):481-93. PubMed ID: 2958570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cellular immunity in leprosy patients].
    de Arruda MS; de Arruda OS; Fleury RN; Garcia Dde O; Opromolla DV; Ura S
    Med Cutan Ibero Lat Am; 1982; 10(4):231-8. PubMed ID: 6763656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological studies in leprosy. III-Cutaneous response to antigens in spectrum of leprosy.
    Singh PK; Ratna ; Jain PK; Mital VP
    Indian J Lepr; 1984; 56(2):257-63. PubMed ID: 6548495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the immunological effects of cimetidine in patients with lepromatous leprosy.
    Brown AE; Nelson KE; Makonkawkeyoon S; Vithayasai V; Scollard DM; Bullock WE
    Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):559-64. PubMed ID: 3910745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte procoagulant activity in man: an in vitro correlate of delayed-type hypersensitivity.
    Geczy CL; Meyer PA
    J Immunol; 1982 Jan; 128(1):331-6. PubMed ID: 6172485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum macrophage migration inhibition activity in patients with leprosy.
    Rea TH; Yoshida T
    J Invest Dermatol; 1982 Nov; 79(5):336-9. PubMed ID: 6752294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
    Smelt AH; Rees RH; Liew FY
    Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response in two groups of anergic patients to the transfer of leukocytes from sensitive donors.
    Rodriguez Paradisi E; De Bonaparte YP; Morgenfeld MC
    N Engl J Med; 1969 Apr; 280(16):859-61. PubMed ID: 4887076
    [No Abstract]   [Full Text] [Related]  

  • 15. Attempts to convert lepromatous into tuberculoid-type leprosy with blood lymphocyte extracts from sensitized donors.
    Silva C; Lima AO; Andrade LM; Mattos O
    Clin Exp Immunol; 1973 Sep; 15(1):87-92. PubMed ID: 4765722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant reactions to tuberculin in lepromatous leprosy patients.
    Waters MF; Stanford JL
    Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):546-53. PubMed ID: 4086918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cell-mediated immune responses in erythema nodosum leprosum reactions of leprosy.
    Rao TD; Rao PR
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):36-41. PubMed ID: 3549939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous responses to antigens and irritants in patients of leprosy.
    Kumar B; Kaur S; Ganguly NK; Sharma S
    Lepr India; 1980 Jul; 52(3):405-10. PubMed ID: 7206636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood monocyte function in leprosy patients.
    Masuda A; Scheinberg MA
    Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):254-9. PubMed ID: 7192267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.